Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Phase II Trial of CHOP vs. Oral Chemotherapy With Concomitant Antiretroviral Therapy in Patients With HIV-Associated Lymphoma in Sub-Saharan Africa

NCT01775475 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT01775475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01775475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Phase II Trial of CHOP vs. Oral Chemotherapy With Concomitant Antiretroviral Therapy in Patients With HIV-Associated Lymphoma in Sub-Saharan Africa
Lead sponsor
AIDS Malignancy Consortium
Phase
Phase 2
Overall status
Completed
Start date
September 15, 2016
Completion date
July 15, 2021
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aids-related diffuse large cell lymphoma, aids-related diffuse mixed cell lymphoma, aids-related diffuse small cleaved cell lymphoma, aids-related immunoblastic large cell lymphoma, aids-related lymphoblastic lymphoma, aids-related peripheral/systemic lymphoma, aids-related small noncleaved cell lymphoma, stage iii aids-related lymphoma, stage iv aids-related lymphoma